News

Article

Optima Pharma Inaugurates Center for Building Turnkey Plants

Optima Pharma opened a new assembly hall, the CSPE Center, that will give the company space to build complete, multi-story pharmaceutical manufacturing facilities.

Optima Pharma opened a new assembly hall, the CSPE Center, that will give the company space to build complete, multi-story pharmaceutical manufacturing facilities, the company announced in a July 2019 press release. 

Optima has invested a double-digit million sum in the new 4600-mbuilding in Schwaebisch Hall's Solpark Industrial Estate in Germany. Construction for the building was originally scheduled to start in 2021, but it was accelerated due to demand. Construction began in October 2018, and the building was completed in April 2019.

In the past year, Optima Pharma introduced the comprehensive scientific process engineering (CSPE) approach, which is a technical and scientific approach that significantly shortens the delivery and commissioning times of complex turnkey plants. “As a result of the new infrastructure, ‘integrated acceptances’ are now possible,” said the company in the press release. The entire system, consisting of isolator and filling and closing machine, has been fully tested and approved on site. 

Source: Optima Pharma

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content